Tag | Content |
---|
EnhancerAtlas ID | HS134-57848 | Organism | Homo sapiens | Tissue/cell | Mesendoderm | Coordinate | chr7:144081140-144082520 | Target genes | | | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
| | Number: 1 | ID | Chromosome | Start | End |
GH07I144383 | chr7 | 144080550 | 144084447 |
| Enhancer Sequence | ATCATAAACT CCTCTTGTTT ATGGGGTCAA ATGAGAATTC CAGTGTTTTG ATATAGTGGC 60 CCTTCACAGA CAGTTATTCC CCACCCATCC CCTCAAGACA CACCACTGAG ACTTGTGCAG 120 GTTTATACTT GTTGATGTTT CAGACTTACA CGTAAATATC TTTTGTGGTG GTAACTCTGC 180 TCTATCGCTA ACACAGTCCA GTGACCCCAG AGCCACACTG GCTGTAAACA TGACTCAGAA 240 GCTGTGTGAT TACAGCAGTT CCAAGCCTGT AGTTGAGGGT AATCTTCTAA CTCTGAAGTC 300 AGGTGTGTGG AAGGGCCGAA GGTTATGAGT AAATGAGCTG AAGAGAGACA GATGCCAAAC 360 TCAGTCGTGA TTCAAATGCA CTTCTTGCTT AGATTTAGAA AACATTCTCT ATGCTTAATA 420 GTCTTTGACC CATTTTTTCC AACCCGCCCA TTGTAAATGA CAGTCATGGA GTGGAAATTT 480 CCCTAGCTTC TTCCTTGGAA GAGCATCCAT TCACCCTGCA GTTCCCAAGG AGCGTCGCAA 540 AAACGAGGCT AAGGGCACAG ACAAAACTCG GGCAGTGAAG GTGAGTGAGT GAGGTTGTTG 600 ATTCTGGGTG GCTGTGAGTG GGGCATCTGT GTAGGAAAGG AGCCGGGTTG GTGTGCGTTA 660 CAAACTTTTT CCGCGCTGCT GGGGTGGGGG TAGCTGGTGT CTGCTGCTCC ATGAATGAGT 720 CATGGGCTGA GGGTAGAACT TGCTCTAGGG AGGGGCTGCG TCTGGCTCAC AGCATTCTCC 780 AGGAGCACCA AGGGGCAGAT GAATATTTTC TGGCAGTTTA CCTGAGCATT TCAGAGAGGC 840 AACTAGCTCT GAACAATGCA GATGGAAACC CAGAAGGAGA GAGGGAGCCA GTCCACATGG 900 TGTGCTGAGA TGGGGGCTCT GCATTTGCTC AGACCAAGGG GCTCCTGAGC ACCAGGGAGA 960 ACATTCAGAC TGTTGGGGAA AGGGTGGGCA AGAGCAACAG ACCGTGGGAT ATTGTGGGAG 1020 AGTCATAGCA GCTCAACAGG ACAGACTGTA GGCTATCCCA GAAGCAGACA GTCTCAGGGA 1080 GAAAAGGGAA ATGCAGAAAG CAAAGAAATG ATGGGCCCTC AGTGGGACTC AGCCAGCCCG 1140 TTCTAAAGTA CTTTCTTATT GAGATCAACG TGTGGTGCAA ATGAGAAAAT TATCCACTGC 1200 TGGATTTGAA AGAACCTTGA AAGTCTTTGT GTCTAACACC CTCACTGGTT ACAGTGGAGC 1260 CTGGAGAGGG GAAGTGATTT ACCTAAGGTC ATACAGTCGG TTGCTTATAA AGGACAGATT 1320 TGTCCAGCTC TATGTCCACT GCTAGGATGT AAGCAAGTGA CCTGCTGAGC TTGTGCTCAT 1380
|
| |
|
|
|